No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
HAE Haemonetics
- 90.990
- +3.330+3.80%
Close Apr 26 16:00 ET
- 90.990
- 0.0000.00%
Post 16:20 ET
4.62BMarket Cap36.99P/E (TTM)
91.580High87.490Low749.02KVolume87.490Open87.660Pre Close67.64MTurnover1.49%Turnover Ratio40.62P/E (Static)50.79MShares95.26052wk High4.90P/B4.58BFloat Cap70.74052wk Low--Dividend TTM50.37MShs Float142.110Historical High--Div YieldTTM4.67%Amplitude6.344Historical Low90.298Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Getting In Cheap On Haemonetics Corporation (NYSE:HAE) Might Be Difficult
With a price-to-earnings (or "P/E") ratio of 33.8x Haemonetics Corporation (NYSE:HAE) may be sending very bearish signals at the moment, given that almost half of all companies in the United States ha
Express News | NYSE Order Imbalance 50408.0 Shares on Sell Side
Haemonetics Is Maintained at Outperform by Barrington Research
Haemonetics Is Maintained at Outperform by Barrington Research
Barrington Research Maintains Outperform on Haemonetics, Maintains $105 Price Target
Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.
Haemonetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 22.12% Barrington Research $105 → $105 Maintains Outperform 02/13/2024 22.12% Barrington Resear
Haemonetics Poised for Growth With Strong Q4 Projections and Strategic Acquisitions
Comments
Despite a recent dip, Haemonetics' robust financials hint at potential long-term stock value growth. High ROE and profit reinvestment suggest promising earnings growth, with analysts predicting continued expansion.
Haemonetics Corporation (NYSE:HAE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?Despite the falling share price, the consistent growth in revenue and EPS could present an investment opportunity if the stock has fallen unfairly. Market expectations may have been unreasonable in the past.
Shareholders appear to hang onto Haemonetics, expecting it to keep beating market trends, due to its projected solid growth. Despite a high P/E, the predicted limited risk of an earnings drop keeps the share price stable.
ColumnsToday's Pre-Market Stock Movers: BBY, BIDU, LCID, FSLR and More
Gapping up
In reaction to earnings/guidance:
• $Gambling.com(GAMB.US$ +5.5%,$Baidu(BIDU.US$ +3.6%,$Best Buy(BBY.US$ +2.4%,$Heico(HEI.US$ +1.4%,$Big Lots(BIG.US$ +0.6%
Other news:
• $FREYR Battery(FREY.US$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
• $Avid Technology(AVID.US$ +9.6% (to join S&P SmallCap 600)
• $RVL Pharmaceuticals(RVLP.US$ +2.3% (Re...
In reaction to earnings/guidance:
• $Gambling.com(GAMB.US$ +5.5%,$Baidu(BIDU.US$ +3.6%,$Best Buy(BBY.US$ +2.4%,$Heico(HEI.US$ +1.4%,$Big Lots(BIG.US$ +0.6%
Other news:
• $FREYR Battery(FREY.US$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
• $Avid Technology(AVID.US$ +9.6% (to join S&P SmallCap 600)
• $RVL Pharmaceuticals(RVLP.US$ +2.3% (Re...
14
4
ColumnsToday's pre-market stock movers: RBLX, TTD, VLD, WYNN and more
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%,$Workiva(WK.US$ +15.3%,$Arlo Technologies(ARLO.US$ +12%,$Array Technologies(ARRY.US$ +10.3%,$Everbridge(EVBG.US$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US$ +9.4%,$Halozyme Therapeutics(HALO.US$ +8.7%,$Velo3D(VLD.US$ +7.6%,$CyberArk(CYBR.US$ + 6.2%,$Haemonetics(HAE.US$ +5.8%,$Jackson Financial(JXN.US$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US$ +4.8%,...
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%,$Workiva(WK.US$ +15.3%,$Arlo Technologies(ARLO.US$ +12%,$Array Technologies(ARRY.US$ +10.3%,$Everbridge(EVBG.US$ +9.7%,$Catalyst Pharmaceuticals(CPRX.US$ +9.4%,$Halozyme Therapeutics(HALO.US$ +8.7%,$Velo3D(VLD.US$ +7.6%,$CyberArk(CYBR.US$ + 6.2%,$Haemonetics(HAE.US$ +5.8%,$Jackson Financial(JXN.US$ +5.7% (also increases dividend),$Axon Enterprise(AXON.US$ +4.8%,...
11
2
CAN I AT LEAST LEARN HOW TO BUY N SELL STOCKS ON THIS Brokerage MOOMOO. 
FOR REAL I DONT GET IT 
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg